apl. Prof. Dr. Jürgen Rech

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Medicine 3 – Rheumatology and Immunology

IL-17-22-23 PATHWAYS IN PSORIATIC ARTHRITIS AND PSORIASIS (2017) Nas K, Cevik R, Yildiz I, Rech J, Schett G Conference contribution CORTICAL BONE LOSS IS AN EARLY FEATURE OF AXIAL SPONDYLOARTHRITIS (2017) Haschka J, Neumann A, Kleyer A, Schuster L, Englbrecht M, Figueiredo CP, Muschitz C, et al. Conference contribution PREVALENCE AND CHARACTERISTICS OF SPONDYLOARTHRITIS ACCORDING TO ASAS CRITERIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE - RESULTS FROM THE SPICE COHORT (2017) Haschka J, Hirschmann S, Kleyer A, Englbrecht M, Zimmermann J, Faustini F, Simon D, et al. Conference contribution Prediction of Response to Certolizumab-Pegol in Rheumatoid Arthritis By Functional MRI of the Brain - an Interim Analysis of an Ongoing Investigator Initiated Phase III Trial (2017) Schenker H, Heß A, Konerth L, Sergeeva M, Prade J, Kleyer A, Reiser M, et al. Conference contribution Innate Lymphoid Cells - New Players in Psoriatic Arthritis (2017) Soare A, Weber S, Maul L, Gheorghiu AM, Housni I, Kleyer A, Luber M, et al. Conference contribution Increased Cartilage Damage in Metacarpophalangeal Joints of ACPA Positive Rheumatoid Arthritis (RA) Patients Using T2 Mapping in 3 Tesla Magnetresonance Imaging (MRI) (2017) Renner N, Kleyer A, Simon D, Krönke G, Rech J, Schett G, Welsch G, Pachowsky M Conference contribution INCREASE OF CORTICAL MICRO-CHANNELS (COMICS) AS A NEW FEATURE OF STRUCTURAL DAMAGE IN PAIENTS WITH RHEUMATOID ARTHRITIS (2017) Werner D, Simon D, Englbrecht M, Stemmler F, Berlin A, Haschka J, Renner N, et al. Conference contribution ELEVATED MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) PREDICTS RELAPSES IN RA PATIENTS IN SUSTAINED REMISSION TAPERING TUMOUR NECROSIS FACTOR INHIBITOR THERAPY-RESULTS FROM THE RANDOMIZED CONTROLLED RETRO STUDY (2017) Rech J, Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, et al. Conference contribution Ustekinumab Is Superior to TNF Inhibitor Treatment in Resolving Enthesitis in Psa Patients with Active Enthesitis-Results from the Enthesial Clearance in Psoriatic Arthritis Study (2017) Guilhon de Araujo E, Englbrecht M, Höpken S, Finzel S, Hueber A, Rech J, Schett G Conference contribution Serum Proteomic Signatures Predict Relapse in Rheumatoid Arthritis Patients Undergoing DMARD Withdrawal (2017) O'Neil L, Spicer V, Hitchon CA, Rech J, Hueber A, Wilkins J, El-Gabalawy H, Schett G Conference contribution